Abstract
The significance of central noradrenergic and dopaminergic neural systems for the locomotor stimulant effects of d-amphetamine were investigated in rats with depletions of norepinephrine, dopamine, or both catecholamines produced by treatment with either reserpine, L-α-methyl-tyrosine (α-MPT), 6-hydroxydopamine (6-OHDA), or the dopamine-Β-hydroxylase inhibitor 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624). In animals pretreated with reserpine, amphetamine-stimulated locomotor activity was blocked by Β-MPT but not by U-14,624 when amphetamine was given l h after these catecholamine synthesis inhibitors. In rats with chronic depletions of brain norepinephrine, dopamine, or both catecholamines produced by different 6-OHDA treatments, both amphetamine-stimulated motor activity and stereotyped behavior were antagonized by treatments reducing dopamine or both catecholamines but not in animals in which brain norepinephrine was reduced. Results are consistent with the view that the locomotor stimulation and stereotyped behaviors produced by d-amphetamine are dependent upon functional dopaminergic neural systems in brain.
Similar content being viewed by others
References
Anden, N.-E., Roos, B. E., Werdinius, B.: Effects of chlorpromazine, haloperidol, and reserpine on the levels of phenolic acids in rabbit corpus striatum. Life Sci. 3, 149–158 (1964)
Anton, A. H., Sayre, D. F.: A study of the factors affecting the aluminum oxidetrihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. exp. Ther. 138, 360–375 (1962)
Anton, A. H., Sayre, D. F.: The distribution of dopamine and dopa in various animals and a method of their determination in diverse biological material. J. Pharmacol. exp. Ther. 145, 326–336 (1964)
Bloom, F. E., Algeri, S., Groppetti, A., Revuetta, A., Costa, E.: Lesions of central norepinephrine terminals with 6-OH-dopamine: Biochemistry and fine structure. Science 166, 1284–1286 (1969)
Breese, G. R., Cooper, B. R., Hollister, A. S.: Relationship of biogenio amines to behavior. In: Catecholamines and their enzymes in the neuropathology of schizophrenia. Suppl. J. psychiat. Res. (in press) (1974a)
Breese, G. R., Cooper, B. R., Smith, R. D.: Biochemical and behavioral alterations following 6-hydroxydopamine administration into brain. Frontiers in catecholamine research: Third International Catecholamine Symposium. S. Snyder and E. Usdin, Eds. London: Pergamon Press (in press) (1974b)
Breese, G. R., Traylor, T. D.: Effects of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J. Pharmacol. exp. Ther. 174, 413–420 (1970)
Breese, G. R., Traylor, T. D.: Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Brit. J. Pharmacol. 42, 88–99 (1971)
Carlsson, A.: Amphetamine and brain catecholamines. In: Amphetamines and related compounds. E. Costa and S. Garattini, Eds., pp. 289–300. New York: Raven Press 1970
Carlsson, A., Fuxe, K., Hamberger, B., Lindquist, M.: Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta physiol. scand. 67, 481–497 (1966)
Christie, J. E., Crow, T. J.: Turning behavior as an index of the action of amphetamines and ephedrines on central dopamine-containing neurones. Brit. J. Pharmacol. 43, 658–667 (1971)
Cooper, B. R., Breese, G. R., Grant, L. D., Howard, J. L.: Effects of 6-hydroxydopamine treatments on active avoidance responding: Evidence for involvement of brain dopamine. J. Pharmacol. exp. Ther. 185, 358–370 (1973)
Cooper, B. R., Breese, G. R., Howard, J. L., Grant, L. D.: Sensitivity to the behavioral depressant effects of reserpine and alpha-methyltyrosine after 6-hydroxydopamine treatment. Psychopharmacologia (Berl.) 27, 99–110 (1972)
Costa, E., Groppetti, A., Naimzada, M. K.: Effects of amphetamine on the turnover rate of brain catecholamines and motor activity. Brit. J. Pharmacol. 44, 742–751 (1972)
Creese, I., Iversen, S. D.: Amphetamine response in rat after dopamine neurone destruction. Nature New Biol. 238, 247–248 (1972)
Creese, I., Iversen, S. D.: Blockade of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res. 55, 369–382 (1973)
Dominic, J. A., Moore, K. E.: Acute effects of α-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice. Arch. int. Pharmacodyn. 178, 166–176 (1969)
Evetts, K. D., Uretsky, N. J., Iversen, L. L., Iversen, S. D.: Effects of 6-hydroxydopamine on CNS catecholamines, spontaneous motor activity, and amphetamine induced hyperactivity in rats. Nature (Lond.) 225, 961–962 (1970)
Fibiger, H. C., Fibiger, H. P., Zis, A. P.: Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat. Brit. J. Pharmacol. 47, 683–692 (1973)
Glowinski, J., Axelrod, J.: Effects of drugs on the uptake, release, and metabolism of H3-norepinephrine in the rat brain, J. Pharmacol. exp. Ther. 149, 43–49 (1965)
Haggendahl, J.: An improved method for fluorometric determination of small amounts of adrenaline and noradrenaline in plasma and tissue. Acta physiol. scand. 59, 242–254 (1963)
Hanson, L. C. F.: Evidence that the central action of amphetamine is mediated via catecholamines. Psychopharmacologia (Berl.) 9, 78–80 (1966)
Hanson, L. C. F.: Evidence that the central action of (+)-amphetamine is mediated via catecholamines. Psychopharmacologia (Berl.) 10, 289–297 (1967)
Hollister, A. S., Cooper, B. R., Breese, G. R.: Evidence for a role of dopamine in amphetamine-induced motor activity and stereotypy. Pharmacologist 15, 254 (1973)
Iversen, S. D.: The effect of surgical lesions to frontal cortex and substantia nigra on amphetamine responses in rats. Brain Res. 31, 295–311 (1971)
Johnson, G. A., Boukma, S. J., Kim, E. G.: In vivo inhibition of dopamine-Β-hydroxylase by l-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624). J. Pharmacol. exp. Ther. 171, 80–87 (1970)
Jonsson, J., Lewander, T.: Effects of diethyldithiocarbamate and ethanol on the in vivo metabolism and pharmacokinetics of amphetamine in the rat. J. Pharm. Pharmacol. 25, 589–591 (1973)
Lapin, I. P., Oxenkrug, G. F., Azbekyan, S. G.: Involvement of brain serotonin in the stimulant action of amphetamine and of cholinolytics. Arch. int. Pharmacodyn. 197, 350–361 (1972)
Mabry, P. D., Campbell, B. A.: Serotonergic inhibition of catecholamine induced behavioral arousal. Brain Res. 49, 381–391 (1973)
Mann, P. J. G., Quastel, J. H.: Benzedrine (Β-phenylisopropylamine) and brain metabolism. Biochem. J. 34, 414–431 (1940)
Marsden, C. A., Guldberg, H. C.: The role of monoamines in rotation induced or potentiated by amphetamine after nigral, raphe and mesencephalic reticular lesions in the rat brain. Neuropharmacol. 12, 195–211 (1973)
McLean, J. R., McCartney, M.: Effect of D-amphetamine on rat brain noradrenaline and serotonin. Proc. Soc. exp. Biol. (N. Y.) 107, 77–79 (1961)
Moore, K. E., Lariviere, E. W.: Effects of D-amphetamine and restraint on the content of norepinephrine and dopamine in rat brain. Biochem. Pharmacol. 12, 1283–1288 (1963)
Naylor, R. J., Olley, J. E.: Modification of the behavioral changes induced by amphetamine in the rat by lesions in the caudate nucleus, the caudate-putamen and globus pallidus. Neuropharmacol. 11, 91–99 (1972)
Oltmans, G. A., Harvey, J. D.: LH syndrome and brain catecholamine levels after lesions of nigro-striatal bundle. Physiol. Behav. 8, 69–78 (1972)
Pletscher, A., Burkhard, W. P., Gey, K. F.: Effect of monoamine releasers and decarboxylase inhibitors on endogenous 5-hydroxyindole derivatives in brain. Biochem. Pharmacol. 13, 385–390 (1964)
Quinton, R. M., Halliwell, G.: Effects of α-methyldopa and DOPA on the amphetamine excitatory response in reserpinized rats. Nature (Lond.) 200, 173–179 (1963)
Randrup, A., Scheel-Krüger, J.: Diethyldithiocarbamate and amphetamine stereotype behavior. J. Pharmacol. 18, 752 (1966)
Reid, W. D.: Turnover rate of brain 5-hydroxytryptamine increased by D-amphetamine. Brit. J. Pharmacol. 40, 483–491 (1970)
Schanberg, S. M., Schildkraut, J. J., Breese, G. R., Kopin, I. J.: Metabolism of normetanephrine in rat brain. Identification of conjugated 3-methoxy-4-hydroxyphenylglycol as the major metabolite. Biochem. Pharmacol. 17, 247–254 (1968)
Simpson, B. A., Iversen, S. D.: Effects of substantia nigra lesions on the locomotor and stereotypy responses to amphetamine. Nature New Biol. 230, 30–32 (1971)
Smith, C. B.: Enhancement by reserpine and α-methyl-DOPA of the effects of d-amphetamine upon locomotor activity of mice. J. Pharmacol. exp. Ther. 142, 343–350 (1963)
Smith, C. B.: Effects of d-amphetamine upon brain amine content and locomotor activity of mice. J. Pharmacol. exp. Ther. 142, 343–350 (1965)
Stein, L., Wise, D., Berger, B.: Noradrenergic reward mechanisms, recovery of function, and schizophrenia. In: The chemistry of mood, motivation, and memory. J. L. McGaugh, Ed., pp. 81–103. New York: Plenum Publishing Corp. 1972
Stolk, J. M., Rech, R. H.: Enhanced stimulant effects of d-amphetamine in rats treated chronically with reserpine. J. Pharmacol. exp. Ther. 163, 75–83 (1968)
Svensson, T. H.: The effect of inhibition of catecholamine synthesis on dexamphetamine induced central stimulation. Europ. J. Pharmacol. 12, 16–166 (1970)
Taylor, K. M., Snyder, S. H.: Differential effects of D-and L-amphetamine on behavior and on catecholamine disposition in dopamine and norepinephrine containing neurons of rat brain. Brain. Res. 28, 295–309 (1971)
Thornberg, J. E.: Relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs. Fed. Proc. 32, 753 (1972)
Ungerstedt, U.: Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior. Acta physiol. scand. 367, 49–68 (1971)
Ungerstedt, U.: Behavioral-anatomical correlates of brain catecholamines. In: Frontiers in catecholamine research. Third International Catecholamine Symposium. S. Snyder and E. Usdin, Eds. London: Pergamon Press (in press) (1974)
Uretsky, N. J., Iversen, L. L.: Effects of 6-hydroxydopamine on catecholamine neurones in the rat brain. J. Neurochem. 17, 269–278 (1970)
Uretsky, N. J., Schoenfeld, R.: Effect of l-DOPA on the locomotor activity of rats pretreated with 6-hydroxydopamine. Nature New Biol. 234, 157–159 (1971)
Van Rossum, J. M., Van der Schoot, J. B., Hurkmans, J. A. T. M.: Mechanism of action of cocaine and amphetamine in the brain. Experientia (Basel) 18, 229–231 (1962)
Von Voigtlander, P. F., Moore, K. E.: Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine. J. Pharmacol. exp. Ther. 184, 542–552 (1973)
Weissman, A., Koe, B. K., Tenen, S. S.: Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 151, 339–352 (1966)
Welch, B. L., Welch, A.: Control of brain catecholamines and serotonin during acute stress and after d-amphetamine by natural inhibition of monoamine oxidase: An hypothesis, In: Amphetamines and related compounds. E. Costa and S. Garattini, Eds., pp. 415–446. New York: Raven Press 1970
White, R. P., Cobb, D. B., Breese, G. R., Nash, C. B.: Acute ergotropic response by reserpine and mephentermine. Int. J. Neuropharmacol. 5, 143–154 (1966)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hollister, A.S., Breese, G.R. & Cooper, B.R. Comparison of tyrosine hydroxylase and dopamine-Β-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity. Psychopharmacologia 36, 1–16 (1974). https://doi.org/10.1007/BF00441377
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00441377